株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CRO (開発業務受託機関) の世界市場予測 2021年:前臨床サービス・臨床研究サービス・ラボサービス

Contract Research Organizations (CROs) Services Market by Type (Preclinical, Clinical Research, Laboratory), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceutical, Biopharmaceutical & Medical Device) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 379870
出版日 ページ情報 英文 269 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
CRO (開発業務受託機関) の世界市場予測 2021年:前臨床サービス・臨床研究サービス・ラボサービス Contract Research Organizations (CROs) Services Market by Type (Preclinical, Clinical Research, Laboratory), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceutical, Biopharmaceutical & Medical Device) - Global Forecast to 2021
出版日: 2016年10月24日 ページ情報: 英文 269 Pages
概要

世界におけるCRO (開発業務受託機関) 市場の規模は、2016年から2021年にかけて7.4%のCAGR (年間複合成長率) で推移し、2016年の292億9,000万米ドルから、2021年までに418億6,000万米ドルに達すると予測されています。同市場の成長は主にR&D支出の増加、R&D活動のアウトソーシングの増加、分析試験・臨床試験サービスのアウトソーシング需要の増加、および治験数の増加によるものです。しかし、CROに対する規制圧力の高まりは、同市場の成長をある程度抑制する可能性があります。

当レポートでは、世界におけるCRO (開発業務受託機関) 市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、サービスタイプ・治療領域・エンドユーザー・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめ、お届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • CRO:市場概要
  • アジア太平洋:CRO市場、臨床研究サービス別
  • CRO市場:地域の成長機会
  • CRO市場:地域ミックス
  • CRO市場:新興 vs. 先進諸国/地域

第5章 CROの世界市場:概要

  • イントロダクション
  • 市場ダイナミクス
    • 主な市場成長促進因子
    • 主な市場成長促進因子
    • 主な市場機会
    • 主な市場課題
  • 産業動向
    • CRO産業における統合の増加
    • 治験のグローバル化

第6章 CROの世界市場:サービスタイプ別

  • イントロダクション
  • 臨床研究サービス
    • フェーズI臨床研究サービス
    • フェーズII臨床研究サービス
    • フェーズIII臨床研究サービス
    • フェーズIV臨床研究サービス
  • 早期開発サービス
    • 創薬研究
    • CMC (化学、製造、品質管理)
    • 前臨床サービス
  • ラボサービス
    • バイオ分析試験サービス
    • 分析試験サービス
  • コンサルティングサービス

第7章 CROの世界市場:治療領域別

  • イントロダクション
  • 中枢神経系 (CNS)
  • 心血管
  • 呼吸器
  • 糖尿病
  • その他の治療領域

第8章 CROの世界市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオ医薬品企業
  • 医療機器企業
  • 大学機関

第9章 CROの世界市場:地域別

  • イントロダクション
  • アジア太平洋
  • 欧州
  • 北米
  • 中東・アフリカ
  • 南米

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第11章 企業プロファイル

  • イントロダクション
  • QUINTILES TRANSNATIONAL HOLDINGS INC.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • PARAXEL INTERNATIONAL CORPORATION
  • PRA HEALTH SCIENCES, INC.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
  • ICON PLC
  • INVENTIV HEALTH INC.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • INC RESEARCH HOLDINGS, INC.
  • WUXI PHARMATECH (CAYMAN) INC.

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PH 4672

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed to growing R&D expenditure, increased outsourcing of R&D activities, growing demand for outsourcing analytical testing and clinical trial services, and increase in the number of clinical trials. However, increasing regulatory pressure on CROs can hinder their market growth to a certain extent.

In this report, the global CRO services market is segmented on the basis of services, therapeutic area, end user, and region. On the basis of services, the market is segmented into early-phase development services, clinical research services, laboratory services, and consulting services. The clinical research services accounted for the largest share of the CROs market in 2015, owing to growing number of biosimilars and biologics by pharmaceutical and biopharmaceutical companies, increase in R&D activities, and growing number of clinical trials.

On the basis of therapeutic area, the oncology segment accounted for the largest share of the CRO services market. The increasing number of clinical trials conducted for oncology and rising prevalence of cancer worldwide are key market drivers for this segment. In 2015, pharmaceutical and biopharmaceutical companies accounted for the largest share of global CRO services market, by end user. The robust pipeline of pharmaceutical and biopharmaceutical companies; growing R&D expenditure; and increasing outsourcing of early-phase development services, clinical research, and laboratory testing services by pharmaceutical and biopharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time of drug development are expected to drive the CRO services market for pharmaceutical and biopharmaceutical companies.

Geographically, the global CRO services market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the global CRO services market. Factors such as high quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics market, rising demand for outsourcing of services by pharmaceutical and biopharmaceutical companies, and increase in clinical trial activities in this region are contributing to the large share of North America. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the fast-growing pharmaceutical industry, favorable government policies, increasing number of pharmaceutical companies establishing manufacturing facilities, and lower cost for clinical trials in this region.

Some of the prominent players in the CRO services market include Quintiles Transnational Holdings Inc. (U.S.), Laboratory Corporation Of America Holdings (U.S.), Pharmaceutical Product Development, LLC (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Charles River Laboratories International Inc. (U.S.), INC Research Holdings Inc. (U.S.), and Wuxi PharmaTech (Cayman) Inc. (China).

Research Coverage:

The report analyzes the outsourcing services provided by CROs across different industries and regions. It aims at estimating the market size and future growth potential of the CRO services market for different segments such as services, therapeutic areas, end users, and regions. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, service development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the services portfolios offered by the top players in the CRO services market. The report analyzes the CRO services market by service, therapeutic area, end user, and region
  • Service Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new service launches in the CRO services market
  • Market Development: Comprehensive information about the lucrative emerging markets
  • Market Diversification: Exhaustive information about new services, growing geographies, recent developments, and investments in the CRO services market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and services, and testing capabilities of leading players in the CRO services market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKET COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CONTRACT RESEARCH ORGANIZATIONS: MARKET OVERVIEW
  • 4.2. ASIA-PASIFIC: CONTRACT RESEARCH ORGANIZATIONS MARKET, BY CLINICAL RESEARCH SERVICE (2015)
  • 4.3. CONTRACT RESEARCH ORGANIZATIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4. CONTRACT RESEARCH ORGANIZATIONS MARKET: GEOGRAPHIC MIX
  • 4.5. CONTRACT RESEARCH ORGANIZATIONS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. KEY MARKET DRIVERS
      • 5.2.1.1. Growing R&D expenditure
      • 5.2.1.2. Growth in outsourcing of R&D activities
      • 5.2.1.3. Increasing demand for outsourcing of analytical testing and clinical trial services
      • 5.2.1.4. Increasing number of clinical trials
    • 5.2.2. KEY MARKET RESTRAINTS
      • 5.2.2.1. Regulatory pressure on contract research organizations
    • 5.2.3. KEY MARKET OPPORTUNITIES
      • 5.2.3.1. Growth in biosimilars and biologics markets
      • 5.2.3.2. Rising demand for specialized testing services
    • 5.2.4. KEY CHALLENGES
      • 5.2.4.1. Growing competition in the contract research organizations industry
      • 5.2.4.2. Regulatory pressure on pharma and medical device manufacturers to drive more detailed analysis of drugs and devices
      • 5.2.4.3. Shortage of skilled professionals
  • 5.3. INDUSTRY TRENDS
    • 5.3.1. GROWING CONSOLIDATION IN THE CRO INDUSTRY
    • 5.3.2. GLOBALIZATION OF CLINICAL TRIALS

6. GLOBAL CROS MARKET, BY TYPE OF SERVICE

  • 6.1. INTRODUCTION
  • 6.2. CLINICAL RESEARCH SERVICES
    • 6.2.1. PHASE I CLINICAL RESEARCH SERVICES
    • 6.2.2. PHASE II CLINICAL RESEARCH SERVICES
    • 6.2.3. PHASE III CLINICAL RESEARCH SERVICES
    • 6.2.4. PHASE IV CLINICAL RESEARCH SERVICES
  • 6.3. EARLY-PHASE DEVELOPMENT SERVICES
    • 6.3.1. DISCOVERY STUDIES
    • 6.3.2. CHEMISTRY, MANUFACTURING, & CONTROL (CMC)
    • 6.3.3. PRECLINICAL SERVICES
      • 6.3.3.1. Pharmacokinetics/pharmacodynamics (pk/pd)
      • 6.3.3.2. Toxicology testing services
      • 6.3.3.3. Other preclinical services
  • 6.4. LABORATORY SERVICES
    • 6.4.1. BIOANALYTICAL TESTING SERVICES
    • 6.4.2. ANALYTICAL TESTING SERVICES
      • 6.4.2.1. Physical characterization
      • 6.4.2.2. Raw material testing
      • 6.4.2.3. Batch-release testing
      • 6.4.2.4. Stability testing
      • 6.4.2.5. Other analytical testing services
  • 6.5. CONSULTING SERVICES

7. GLOBAL CROS MARKET, BY THERAPEUTIC AREA

  • 7.1. INTRODUCTION
  • 7.2. ONCOLOGY
  • 7.3. CENTRAL NERVOUS SYSTEM (CNS)
  • 7.4. CARDIOVASCULAR
  • 7.5. RESPIRATORY
  • 7.6. DIABETES
  • 7.7. OTHER THERAPEUTIC AREAS

8. GLOBAL CROS MARKET, BY END-USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 8.3. MEDICAL DEVICE COMPANIES
  • 8.4. ACADEMIC INSTITUTES

9. GLOBAL CROS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. U.K.
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE (ROE)
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. LATIN AMERICA
    • 9.5.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATIONS AND TRENDS
    • 10.3.1. AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS
    • 10.3.2. SERVICE LAUNCHES
    • 10.3.3. EXPANSIONS
    • 10.3.4. MERGERS AND ACQUISITIONS
    • 10.3.5. SERVICE ENHANCEMENTS

11. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 11.1. INTRODUCTION
  • 11.2. QUINTILES TRANSNATIONAL HOLDINGS INC.
  • 11.3. LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 11.4. PARAXEL INTERNATIONAL CORPORATION
  • 11.5. PRA HEALTH SCIENCES, INC.
  • 11.6. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
  • 11.7. ICON PLC
  • 11.8. INVENTIV HEALTH INC.
  • 11.9. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 11.10. INC RESEARCH HOLDINGS, INC.
  • 11.11. WUXI PHARMATECH (CAYMAN) INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: BUSINESS EXPENDITURE ON R&D IN THE PHARMACEUTICAL INDUSTRY, BY COUNTRY/REGION, 2005-2011 (USD BILLION)
  • TABLE 2: EXPENDITURE ON R&D BY FUNCTION, PHRMA MEMBER COMPANIES (2013)
  • TABLE 3: ACTIVITIES OUTSOURCED IN THE PHARMACEUTICAL INDUSTRY (2014 VS. 2015)
  • TABLE 4: INCREASING DEMAND FOR OUTSOURCING OF ANALYTICAL TESTING AND CLINICAL TRIAL SERVICES TO DRIVE MARKET GROWTH
  • TABLE 5: REGULATORY PRESSURE ON CONTRACT RESEARCH ORGANIZATIONS TO RESTRAIN MARKET GROWTH
  • TABLE 6: CLINICAL STUDIES FOR BIOLOGIC & BIOSIMLAR MOLECULES (2016)
  • TABLE 7: GROWING BIOSIMILARS AND BIOLOGICS MARKETS TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 8: OVERVIEW OF REGULATORY GUIDELINES
  • TABLE 9: REGULATORY PRESSURE ON PHARMA AND MEDICAL DEVICE MANUFACTURES TO PROVIDE MORE DETAILED ANALYSIS OF DRUGS & DEVICES IS A MAJOR CHALLENGE IN THE MARKET
  • TABLE 10: MAJOR ACQUISITIONS IN CRO INDUSTRY (2013-2016)
  • TABLE 11: GLOBAL CROS MARKET SIZE, BY TYPE OF SERVICE, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL CROS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: PHASE I CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL PHASE II CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL PHASE III CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL PHASE IV CLINICAL RESEARCH SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: GLOBAL EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 20: GLOBAL EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL DISCOVERY STUDIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL CHEMISTRY, MANUFACTURING, & CONTROL (CMC) SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL PRECLINICAL SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL PHARMACOKINETICS/PHARMACODYNAMICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL TOXICOLOGY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL OTHER PRECLINICAL SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: GLOBAL LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL PHYSICAL CHARACTERIZATION SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL RAW MATERIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL BATCH-RELEASE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: GLOBAL STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL OTHER ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL NUMBER OF CLINICAL TRIALS IN DIFFERENT THERAPEUTIC AREAS, 2016
  • TABLE 40: GLOBAL CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 41: GLOBAL CROS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: GLOBAL CROS MARKET SIZE FOR CNS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL CROS MARKET SIZE FOR CARDIOVASCULAR, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL CROS MARKET SIZE FOR RESPIRATORY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: GLOBAL CROS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: GLOBAL CROS MARKET SIZE FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: GLOBAL CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 48: GLOBAL CROS MARKET SIZE FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL CROS MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: GLOBAL CROS MARKET SIZE FOR ACADEMIC INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: GLOBAL CROS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: CROS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: NORTH AMERICA: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 61: TOTAL NUMBER OF CLINICAL TRIALS IN THE U.S. (2016)
  • TABLE 62: U.S.: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 63: U.S.: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: U.S.: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: U.S.: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: U.S.: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: U.S.: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: U.S.: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 69: U.S.: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 70: NUMBER OF CLINICAL TRIALS FOR SMALL MOLECULES, BIOSIMILARS, AND MEDICAL DEVICES IN CANADA (2016)
  • TABLE 71: R&D EXPENDITURE IN CANADA IN DIFFERENT PHASES, 2013 & 2014
  • TABLE 72: CANADA: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 73: CANADA: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: CANADA: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: CANADA: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: CANADA: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: CANADA: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: CANADA: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 79: CANADA: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY, 2012 & 2014
  • TABLE 81: EUROPE: CROS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 82: EUROPE: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 83: EUROPE: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: EUROPE: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 87: EUROPE: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: EUROPE: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 89: EUROPE: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: PHARMACEUTICAL INDUSTRY R&D INVESTMENTS IN GERMANY (2010-2014)
  • TABLE 91: BIOTECHNOLOGY INDUSTRY IN GERMANY (2009-2014)
  • TABLE 92: GERMANY: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 93: GERMANY: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: GERMANY: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 95: GERMANY: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: GERMANY: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: GERMANY: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: GERMANY: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 99: GERMANY: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 100: U.K.: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 101: U.K.: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: U.K.: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: U.K.: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2019 (USD MILLION)
  • TABLE 104: U.K.: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2019 (USD MILLION)
  • TABLE 105: U.K.: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2019 (USD MILLION)
  • TABLE 106: U.K.: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 107: U.K.: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 108: FRANCE: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 109: FRANCE: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: FRANCE: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 111: FRANCE: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 112: FRANCE: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: FRANCE: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 114: FRANCE: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 115: FRANCE: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 116: PHARMACEUTICAL R&D INVESTMENTS IN ITALY, 2009-2014
  • TABLE 117: CLINICAL TRIALS PER DRUG TYPOLOGY (2013 & 2014)
  • TABLE 118: CLINICAL TRIALS PER THERAPEUTIC AREA (2013& 2014)
  • TABLE 119: ITALY: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 120: ITALY: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 121: ITALY: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: ITALY: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: ITALY: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 124: ITALY: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: ITALY: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 126: ITALY: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 127: SPAIN: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 128: SPAIN: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: SPAIN: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 130: SPAIN: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 131: SPAIN: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: SPAIN: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: SPAIN: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 134: SPAIN: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 135: PHARMACEUTICAL R&D EXPENDITURE IN BELGIUM (2010-2014)
  • TABLE 136: PHARMACEUTICAL PRODUCTION AND R&D EXPENDITURE IN DENMARK, 2012-2014
  • TABLE 137: ROE: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 138: ROE: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 139: ROE: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 140: ROE: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 141: ROE: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: ROE: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 143: ROE: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 144: ROE: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 145: TOTAL NUMBER OF CLINICAL TRIALS IN APAC, BY THERAPEUTIC AREA,2016
  • TABLE 146: ASIA-PACIFIC: CROS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 147: ASIA-PACIFIC: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 148: ASIA-PACIFIC: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 149: ASIA-PACIFIC: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 150: ASIA-PACIFIC: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 151: ASIA-PACIFIC: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 152: ASIA-PACIFIC: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 153: ASIA-PACIFIC: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 154: ASIA-PACIFIC: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 155: COST OF CLINICAL TRIALS: U.S. & CHINA (2012)
  • TABLE 156: CHINA: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 157: CHINA: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 158: CHINA: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 159: CHINA: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 160: CHINA: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 161: CHINA: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 162: CHINA: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 163: CHINA: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 164: JAPAN: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 165: JAPAN: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 166: JAPAN: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 167: JAPAN: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 168: JAPAN: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 169: JAPAN: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 170: JAPAN: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 171: JAPAN: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 172: INDIA: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 173: INDIA: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 174: INDIA: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 175: INDIA: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 176: INDIA: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 177: INDIA: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 178: INDIA: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 179: INDIA: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 180: REST OF ASIA-PACIFIC: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 181: REST OF ASIA-PACIFIC: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 182: REST OF ASIA-PACIFIC: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 183: REST OF ASIA-PACIFIC: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 184: REST OF ASIA-PACIFIC: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 185: REST OF ASIA-PACIFIC: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 186: REST OF ASIA-PACIFIC: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 187: REST OF ASIA-PACIFIC: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 188: ROW: CROS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 189: ROW: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 190: ROW: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 191: ROW: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 192: ROW: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 193: ROW: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 194: ROW: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 195: ROW: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 196: ROW: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 197: LATIN AMERICA: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 198: LATIN AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 199: LATIN AMERICA: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 200: LATIN AMERICA: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2012 (USD MILLION)
  • TABLE 201: LATIN AMERICA: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2012 (USD MILLION)
  • TABLE 202: LATIN AMERICA: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2012 (USD MILLION)
  • TABLE 203: LATIN AMERICA: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 204: LATIN AMERICA: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 205: MIDDLE EAST AND AFRICA: CROS MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 206: MIDDLE EAST AND AFRICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 207: MIDDLE EAST AND AFRICA: PRECLINICAL SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 208: MIDDLE EAST AND AFRICA: CLINICAL RESEARCH SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 209: MIDDLE EAST AND AFRICA: LABORATORY SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 210: MIDDLE EAST AND AFRICA: ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 211: MIDDLE EAST AND AFRICA: CROS MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 212: MIDDLE EAST AND AFRICA: CROS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 213: GROWTH STRATEGY MATRIX, 2013-2016
  • TABLE 214: AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS, 2013-2016
  • TABLE 215: SERVICE LAUNCHES, 2013-2016
  • TABLE 216: EXPANSIONS, 2013-2016
  • TABLE 217: MERGERS AND ACQUISITIONS, 2013-2016
  • TABLE 218: SERVICE ENHANCEMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS OF THE GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET
  • FIGURE 7: CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY SERVICE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY THERAPEUTIC AREA, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY END-USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GEOGRAPHIC SNAPSHOT OF THE CONTRACT RESEARCH ORGANIZATIONS MARKET
  • FIGURE 11: GROWTH STRATEGY MATRIX OF THE TOP 5 PLAYERS IN THE GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET
  • FIGURE 12: INCRESING DEMAND OF OUTSOURCING ANALYTICAL TESTING AND CLINICAL TRIALS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: PHASE III CLINICAL RESEARCH SERVICES DOMINATED THE APAC CLINICAL RESEARCH SERVICES MARKET IN 2015
  • FIGURE 14: THE U.S. DOMINATED THE GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET IN 2015
  • FIGURE 15: NORTH AMERICA TO DOMINATE THE CONTRACT RESEARCH ORGANIZATIONS MARKET IN 2016
  • FIGURE 16: CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: CONTRACT RESEARCH ORGANIZATIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: TOTAL NUMBER OF REGISTERED STUDIES (2005-2016)
  • FIGURE 19: NUMBER OF CLINICAL TRIALS, BY COUNTRY (2016)
  • FIGURE 20: TOTAL NUMBER OF NEW MOLECULAR ENTITY (NME) APPROVALS & NEW BIOLOGICS LICENSE APPLICATIONS (BLA) (2005-2015)
  • FIGURE 21: GROWING CONSOLIDATION IN THE CRO INDUSTRY AND GLOBALIZATION OF CLINICAL TRIALS ARE THE LEADING INDUSTRY TRENDS
  • FIGURE 22: BIOLOGIC MEDICINES IN DEVELOPMENT, BY THERAPEUTIC AREA, 2013
  • FIGURE 23: PHASES OF DRUG DISCOVERY STUDIES
  • FIGURE 24: TOTAL NUMBER OF CLINICAL TRIALS FOR ONCOLOGY (2016)
  • FIGURE 25: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE THE CROS MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: R&D SPENDING OF PHRMA MEMBER COMPANIES, 1980-2015
  • FIGURE 27: CLINICAL STUDIES ON MEDICAL DEVICES (2016)
  • FIGURE 28: GEOGRAPHIC SNAPSHOT (2016): APAC MARKETS ARE EMERGING AS NEW GROWTH HOTSPOTS
  • FIGURE 29: TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2016)
  • FIGURE 30: NORTH AMERICA: CONTRACT RESEARCH ORGANIZATIONS MARKET SNAPSHOT
  • FIGURE 31: PHARMACEUTICAL R&D EXPENDITURE IN THE U.S. (1990-2014)
  • FIGURE 32: PHARMACEUTICAL R&D EXPENDITURE IN EUROPE (2010-2014)
  • FIGURE 33: APAC: CONTRACT RESEARCH ORGANIZATIONS MARKET SNAPSHOT
  • FIGURE 34: CLINICAL TRIAL PHASES CONDUCTED IN AUSTRALIA, 2013
  • FIGURE 35: AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS-KEY GROWTH STRATEGIES PURSUED BY MARKET PLAYERS BETWEEN 2013 & 2016
  • FIGURE 36: GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 37: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS WAS THE KEY STRATEGY
  • FIGURE 38: GEOGRAPHICAL REVENUE MIX OF THE TOP 4 PLAYERS
  • FIGURE 39: QUINTILES TRANSNATIONAL HOLDINGS INC.: COMPANY SNAPSHOT
  • FIGURE 40: LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • FIGURE 41: PARAXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
  • FIGURE 42: PRA HEALTH SCIENCES, INC.: COMPANY SNAPSHOT
  • FIGURE 43: ICON PLC: COMPANY SNAPSHOT
  • FIGURE 44: INVENTIV HEALTH INC.: COMPANY SNAPSHOT
  • FIGURE 45: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • FIGURE 46: INC RESEARCH HOLDINGS, INC.: COMPANY SNAPSHOT
  • FIGURE 47: WUXI PHARMATECH (CAYMAN) INC.: COMPANY SNAPSHOT
Back to Top